EGFR-targeting peptide-coupled platinum(IV) complexes
نویسندگان
چکیده
منابع مشابه
Charge Transfer Between Quantum Dots and Peptide-Coupled Redox Complexes
Introduction: Nanotechnology has great potential for creating a new generation of multifunctional hybrid bio-inorganic assemblies that are capable of enhancing Navy capabilities and DoD battle systems in general. The unique properties of luminescent quantum dots (QDs) have made them an integral building block in this burgeoning field.1 In addition to their well known size-dependent emission spe...
متن کاملMultifunctional gold nanoparticle-peptide complexes for nuclear targeting.
The ability of peptide-modified gold nanoparticles to target the nucleus of HepG2 cells was explored. Five peptide/nanoparticle complexes were investigated, particles modified with (1) the nuclear localization signal (NLS) from the SV 40 virus; (2) the adenovirus NLS; (3) the adenovirus receptor-mediated endocytosis (RME) peptide; (4) one long peptide containing the adenovirus RME and NLS; and ...
متن کاملEGFR targeting of solid tumors.
BACKGROUND Recent clinical trials suggest that epidermal growth factor receptor (EGFR)-targeted agents could benefit many patients with cancer. METHODS We review the current status of several EGFR-targeted therapies in cancer patients and address the efficacy of theses drugs as monotherapy or in combination with other drugs and/or treatments. RESULTS Cetuximab is the most widely studied ant...
متن کاملDual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
We have recently demonstrated that complexation with (η(6)-arene)Ru(II) fragments confers 4-anilinoquinazoline pharmacophores a higher potential for inducing cellular apoptosis while preserving the highly inhibitory activity of 4-anilinoquinazolines against EGFR and the reactivity of the ruthenium centre to 9-ethylguanine (Chem. Commun., 2013, 49, 10224-10226). Reported herein are the synthesis...
متن کاملTargeting the EGFR pathway for cancer therapy.
Clinical studies have shown that HER-2/Neu is over-expressed in up to one-third of patients with a variety of cancers, including B-cell acute lymphoblastic leukemia (B-ALL), breast cancer and lung cancer, and that these patients are frequently resistant to conventional chemo-therapies. Additionally, in most patients with multiple myeloma, the malignant cells over-express a number of epidermal g...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JBIC Journal of Biological Inorganic Chemistry
سال: 2017
ISSN: 0949-8257,1432-1327
DOI: 10.1007/s00775-017-1450-7